RMD - Resmed Inc Stock Analysis
Resmed Inc (RMD) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 32.99B, generates annual revenue of 5.65B, and reports net income of 1.52B. As of the latest data, the stock is trading at 234.60 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (1.13%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.52), indicating current market sentiment. Institutional ownership is reported at 74.68%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -13.75%, trading within a 52-week range of 180.26 - 277.85.
RMD - Resmed Inc
234.60
Analyst Consensus
Hold 3.52
RMD – Analyst Rating Summary
- Strong Buy: 4
- Buy: 9
- Hold: 12
- Sell: 1
- Strong Sell: 1
- Total Analysts: 27
| Index: | S&P 500 | P/E: | 22.48 | EPS (ttm): | 10.44 | Insider Own: | 0.94% | Shs Outstand: | 144.24M | Perf Week: | 5.27% |
| Market Cap: | 32.99B | Forward P/E: | 17.64 | EPS next Y: | 13.30 | Insider Trans: | -2.86% | Shs Float: | 139.32M | Perf Month: | 7.48% |
| Income(ttm): | 1.52B | PEG: | 1.91 | EPS next Q: | 2.68 | Inst Own: | 74.68% | Short Float: | 9.18% | Perf Quarter: | 21.55% |
| Revenue(ttm): | 5.65B | P/S: | 5.84 | EPS this Y: | 8.28% | Inst Trans: | 0.84% | Short Ratio: | 9.68 | Perf Half Y: | 1.88% |
| Book/sh: | 45.66 | P/B: | 5.14 | EPS next Y: | 9.95% | ROA: | 17.77% | Short Interest: | 12.78M | Perf Year: | -13.75% |
| Cash/sh: | 10.47 | P/C: | 22.41 | EPS next 5Y: | 9.24% | ROE: | 24.27% | 52W Range: | 180.26 - 277.85 | Perf YTD: | -2.60% |
| Dividend Est.: | 2.65 (1.13%) | P/FCF: | 20.00 | EPS past 3/5Y: | 19.66% 26.34% | ROIC: | 21.39% | 52W High: | 277.85 -15.57% | Beta: | 0.78 |
| Dividend TTM: | 2.46 (1.05%) | Quick Ratio: | 2.42 | Sales past 3/5Y: | 10.21% 12.08% | Gross Margin: | 60.25% | 52W Low: | 180.26 30.14% | Perf 5Y: | -7.00% |
| Dividend Ex-Date: | Aug 20, 2026 | Current Ratio: | 3.10 | EPS Y/Y TTM: | 9.65% | Oper. Margin: | 34.01% | RSI (14): | 65.76 | Volatility: | 2.40% 2.25% |
| Employees: | 11370 | Debt/Eq: | 0.13 | Sales Y/Y TTM: | 9.85% | Profit Margin: | 26.94% | Recom: | 2.07 | Target Price: | 260.96 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.08 | EPS Q/Q: | 2.42% | Payout: | 23.01% | Rel Volume: | 0.80 | Prev Close: | 230.05 |
| Sales Surprise: | 0.16% | EPS Surprise: | 1.98% | Sales Q/Q: | 8.58% | Earnings: | Oct 29 AMC | Avg Volume: | 1.32M | Price: | 234.60 |
| SMA20: | 4.50% | SMA50: | 3.96% | SMA200: | 4.20% | Undervalued: 11.24% | Volume: | 1,051,205 | Change: | 1.98% | |
Graham Classic formula value: 252.93
(P/E=8 * 1g) Min value: 161.62
(current P/E * 2g) Max value: 383.99
Average value: 266.18
About Resmed Inc
ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment relates primarily to the sale of therapy-based equipment. The Residential Care Software segment provides software access with ongoing support and maintenance services as well as professional services such as training and consulting. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.